Manufacturers outside the EU/EEA area

Updated 01 February 2024

When a medicinal product is manufactured at a company in a third country, i.e. outside the EU/EEA, an increased application fee and an increased annual fee are charged.

In 2024, the application/annual fee was increased to DKK 1,130. However, the fee is payable for maximum one strength per pharmaceutical form.

The increased annual fee has item number 3048, and the increased application fee has item number 3049.

The increased application fee is charged in connection with the application, whereas the increased annual fee is charged at the end of each year.